Use of Combined Oral Contraceptives in Perimenopausal Women

조문경 2018년
논문상세정보
    • 저자 조문경
    • 제어번호 105914926
    • 학술지명 전남의대학술지
    • 권호사항 Vol. 54 No. 3 [ 2018 ]
    • 발행처 전남대학교 의과학연구소
    • 자료유형 학술저널
    • 수록면 153-158
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 강원대학교 춘천캠퍼스 도서관 의학분관 경북대학교 도서관 의학분관
    • 판매처
    유사주제 논문( 0)

' Use of Combined Oral Contraceptives in Perimenopausal Women' 의 참고문헌

  • U.S. Selected Practice Recommendations for contraceptive Use, 2016
    Curtis KM [2016]
  • U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
    Curtis KM [2016]
  • Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding
    Davis A [2000]
  • Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review
    Godfrey EM [2013]
  • The risk of venous thromboembolism with different generation of oral contraceptives; a systematic review and meta-analysis
    Baratloo A [2014]
  • The normal menstrual cycle in women
    Mihm M [2011]
  • The menopausal transition (perimenopause): what is it?
  • The North American Menopause Society recommendations for clinical care of midlife women
    Shifren JL [2014]
  • Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis
  • Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis
    Nelson HD [2012]
  • Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year
  • Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia
    Fraser IS [1991]
  • Psychosocial, behavioral, and health factors related to menopause symptomatology
    Avis NE [1997]
  • Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls
  • Oral-contraceptive use and risk of hip fracture: a case-control study
  • Oral contraceptives and the risk of breast cancer
  • Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis
    Bosetti C [2009]
  • Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review
    Gierisch JM [2013]
  • Oral contraceptive use and risk of breast cancer: a meta-analysis of prospective cohort studies
    Zhu H [2012]
  • Oral contraception for women of middle age
    Ruan X [2015]
  • Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest
    Fraser IS [2012]
  • Low-dose oral contraceptives and bone mineral density: an evidence-based analysis
    Kuohung W [2000]
  • Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density
  • Long term hormone therapy for perimenopausal and postmenopausal women
  • Laboratory criteria for menopause in women using oral contraceptives
    Creinin MD [1996]
  • Incidence of venous thromboembolism in Korea: from the health insurance review and assessment service database
    Jang MJ [2011]
  • Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study
    Shargil AA [1985]
  • Hormonal contraceptive regimens in the perimenopause
    Hardman SM [2009]
  • Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval
    Sulak P [2007]
  • Executive summary of the stages of reproductive aging workshop +10: Addressing the unfinished agenda of staging reproductive aging
  • Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies
  • Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial
    Jensen JT [2011]
  • Do women aged over 40 need different counseling on combined hormonal contraception?
    Mendoza N [2016]
  • Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
    Stegeman BH [2013]
  • Contraceptive technology
    Trussell J [2011]
  • Contraception for the perimenopausal woman
    Linton A [2016]
  • Contraception during the perimenopause
    Baldwin MK [2013]
  • Contraception and sexual health 2007/08
    Lader D [2007]
  • Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contracept
    Edelman AB [2005]
  • Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
    Edelman A [2014]
  • Comparison of the metabolic effects of oral contraceptive and nonhormonal contraceptive use in women over 40 years old
    Suwikrom S [2005]
  • Combined oral contraceptives: venous thrombosis
    de Bastos M [2014]
  • Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
    Roach RE [2015]
  • Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects
    Lurie G [2008]
  • Clinical practice. Hormonal contraception in women of older reproductive age
    Kaunitz AM [2008]
  • Changes with age in the level and duration of fertility in the menstrual cycle
    Dunson DB [2002]
  • Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
  • Bone mineral density in postmenopausal women as determined by prior oral contraceptive use
  • Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial
    Kwiecien M [2003]
  • An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome
    Freeman EW [2012]
  • ACOG Committee Opinion Number 540: risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills
  • A scheme of combined oral contraceptives for women more than 40 years old
    Blumel JE [2001]
  • 20 <TEX>${\mu}g$</TEX> versus >20 <TEX>${\mu}g$</TEX> estrogen combined oral contraceptives for contraception
    Gallo MF [2013]